Bone marrow hypocellularity, anemia and severe neutropenia have been observed in macaques treated daily with human recombinant IL-15 by subcutaneous injection [45] and, more importantly, recently similar side effects have been observed in first in human clinical trial of recombinant-IL15. This evidence concerns the gene IL15 and anemia.